Celldex Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-30.4M | $-32.5M | $2.1M | $2.8M |
| FY2011 | $-35.7M | $-36.2M | $509.0K | $2.3M |
| FY2012 | $-49.8M | $-50.1M | $303.0K | $2.3M |
| FY2013 | $-67.7M | $-71.9M | $4.2M | $4.5M |
| FY2014 | $-101.5M | $-103.5M | $1.9M | $6.9M |
| FY2015 | $-98.9M | $-103.8M | $4.9M | $12.8M |
| FY2016 | $-113.0M | $-115.8M | $2.8M | $15.3M |
| FY2017 | $-99.9M | $-101.7M | $1.8M | $12.3M |
| FY2018 | $-75.2M | $-76.0M | $813.0K | $8.1M |
| FY2019 | $-46.4M | $-47.1M | $731.0K | $4.6M |
| FY2020 | $-40.4M | $-42.0M | $1.6M | $3.9M |
| FY2021 | $-60.9M | $-62.2M | $1.2M | $9.0M |
| FY2022 | $-103.7M | $-105.6M | $1.8M | $15.6M |
| FY2023 | $-107.3M | $-109.1M | $1.8M | $23.9M |
| FY2024 | $-157.8M | $-159.7M | $1.9M | $34.2M |
| FY2025 | $-210.9M | $-213.7M | $2.7M | $36.2M |